The authorisation comes three months after the MHRA approved Johnson & Johnson’s Lazcluze (lazertinib), which is also ...

Otsuka Pharmaceutical has shared positive results from a late-stage study of its investigational monoclonal antibody ...

Mental health awareness has seen incredible change – in no small part down to communications teams in private and public ...

What does SAY’s healthcare communications crystal ball reveal for the coming year? We’ve looked at what we can expect to see ...

Artificial intelligence (AI) is rapidly transforming industries. Healthcare is no exception. The conversation around AI’s ...

Medscape Hematology will be at EHA 2025 to showcase the power of education impact through online abstracts, posters, and 4 ...

AstraZeneca (AZ) has announced that its fixed-duration Calquence (acalabrutinib)-based regimens have been approved by the ...

In the rapidly evolving landscape of healthcare and pharmaceutical market access, data analytics has become a critical ...

Eli Lilly and Camurus have entered into partnership worth up to $870m to develop long-acting therapies in cardiometabolic ...

Regeneron Pharmaceuticals has announced that it will be gaining rights to Hansoh Pharmaceuticals’ investigational dual ...

I also miss the immersive nature of in-person events – no distractions and no clinical responsibilities, just dedicated time ...

That word ‘creativity’ can make our eyes roll, light up, or widen in panic, depending on our mood and workload. Thanks to new ...